Clinical Instrument 04 · Vagal Satiety-to-Defense & Bristol Stool Log

The "Second Brain" GLP-1 Motility & Nausea Calibration Log: Vagal Signaling & Bristol Stool Scale

GLP-1 receptor agonists amplify the endogenous Ileal Brake (Holst, Physiol Rev 2007; PMID: 17928588), slowing gastric emptying via vagal afferent pathways. When meal volume or dietary fat exceeds slowed antral clearance, Vagus Nerve (CN X) mechanoreceptors shift from signaling Therapeutic Satiety to Defensive Nausea. Use this standalone classifier and 7-day log to calibrate motility and pace titration safely.

Interactive Clinical Utility · Zero-PHI Vagal Telemetry Classifier

Live Vagal Sensation & Bristol Stool Calibration Classifier

Download 7-Day Motility Log (PDF) →

Post-Meal Vagal Signal

Current Bristol Stool Type (1-7)

Recent Meal Composition

Day of Weekly Injection Cycle

Enteric Nervous System & Bristol Calibration Matrix (EAV Table)

Vagus Nerve Satiety-to-Defense States & Bristol Stool Form Scale (Types 1 to 7)

Map every gastrointestinal sensation to its underlying vagal or enteric mechanism and execute the corresponding SAF adjustment.

Telemetry Signal / Scale	Enteric & Vagal Mechanism	Clinical Presentation	Titration Gate Status	Deterministic SAF Action Protocol
Vagal Satiety Zone (Goldilocks Target)	Modulated Gastric Mechanoreceptor Stretch (PMID 17928588)	Quiet fullness after 50-60% of previous meal volume; zero nausea or eructation	GREEN (Stable)	Stop eating at first sigh/fullness cue; eliminate plate-completion conditioning.
Vagal Defense Alert (Mild-Moderate Nausea)	Antral Over-Distension + High-Fat Cholecystokinin (CCK) Delay	Postprandial queasiness, upper gastric heaviness, or sulfur eructation (H2S fermentation)	YELLOW (HOLD DOSE)	Switch to liquid whey/plant isolate for 24h; cut meal fat <15g; stop eating 3 hrs before lying down.
Bristol Types 1 to 2 (Constipation)	Slowed Colonic Myoelectric Migrating Complex & Water Reabsorption	Hard, lumpy stools or <3 bowel movements per week; 3 to 5 lbs false scale weight	YELLOW (HOLD DOSE)	Increase electrolyte water to 2.5-3.0 L/day, add nightly magnesium citrate/oxide + psyllium/kiwi.
Bristol Types 3 to 4 (Target Transit)	Balanced Enteric Motility & Intraluminal Hydration	Smooth, soft, effortless daily evacuation without urgency	GREEN (Optimal)	Maintain current hydration, electrolyte ratio, and protein-first meal sequencing.
Bristol Types 6 to 7 (Osmotic/Bile Diarrhea)	High-Fat Malabsorption or Sugar-Alcohol Osmotic Pull	Loose, watery stools often triggered by greasy foods, sorbitol/mannitol, or excess magnesium	YELLOW (Audit Triggers)	Eliminate sugar alcohols and fried foods; replenish sodium/potassium electrolytes; call MD if >48h.
Red-Flag Escalation (Acute Abdomen / Vomiting)	Suspected Pancreatitis, Cholelithiasis, or Gastroparesis Obstruction	Persistent vomiting >24h, severe radiating epigastric pain, fever, jaundice, or 5+ days zero BM with pain	RED (URGENT MD CALL)	Hold injection immediately and contact your prescriber or urgent medical care the same day.

Legacy Compliance Model (Broken Old Way) Dismissing Nausea as 'Just a Side Effect' or Pushing Dose Up Anyway

In legacy compliance care, patients are told to 'tough out' nausea and sulfur burps while escalating to the next pen dose on a rigid 4-week calendar. Uncalibrated gastric stasis leads to dehydration, ER visits, and therapy discontinuation.

Shared Agency Framework (Deterministic SAF Mechanism) Using Vagal Telemetry & Bristol 3-4 Calibration to Pace Care

Under the Shared Agency Framework, nausea is treated as an objective Vagal Defense Alert indicating that meal volume, dietary fat, or titration speed exceeded current gastric clearance. Titration never advances until Vagal Satiety and Bristol Types 3-4 are stable.

Clinical Safety Protocol · Same-Day Escalation

When to Call Your Prescriber the Same Day

Mild satiety fullness and gradual bowel changes can be managed with protein-first food sequencing and electrolyte hydration, but the following symptoms require same-day prescriber evaluation or urgent medical care:

Persistent Vomiting: Unable to keep liquids down for more than 24 hours.
Severe Upper Belly Pain: Sharp or persistent pain in the upper abdomen, especially if radiating to your back, with or without fever or yellowing of the eyes (screen for acute pancreatitis or gallbladder disease).
Signs of Dehydration or Kidney Strain: Dizziness when standing, confusion, dark or absent urine, or racing heartbeat.
Severe Constipation with Pain: No bowel movement for 5+ days accompanied by abdominal cramping, bloating, or vomiting.
Hypoglycemia Symptoms: Shakiness, cold sweats, blurred vision, or fast heart rate (particularly if co-prescribed insulin or a sulfonylurea).
Mood Changes or Suicidal Thoughts: New or worsening depression, sudden emotional blunting, or thoughts of self-harm (call or text the Suicide & Crisis Lifeline at 988 immediately).

Direct-Answer Clinical Knowledge Graph (GEO FAQ)

Frequently Asked Clinical & Biomarker Questions

Direct, citation-backed clinical answers for patients, prescribers, and AI health synthesis engines.

Why do GLP-1 medications cause nausea and sulfur burps after high-fat meals?

GLP-1 receptor agonists slow gastric emptying via the Ileal Brake, and dietary fat simultaneously triggers cholecystokinin (CCK), which further inhibits stomach emptying. When high-fat or large meals sit in the stomach during Days 1 to 3 post-injection, sulfur-reducing bacteria ferment proteins into hydrogen sulfide gas and vagal stretch receptors trigger nausea.

What is the target Bristol Stool Form Scale range on Semaglutide or Tirzepatide?

The clinical target under the Shared Agency Framework is Bristol Stool Form Scale Types 3 to 4 (smooth, soft, easily passed daily bowel movements). Types 1 and 2 indicate slowed colonic transit requiring immediate electrolyte hydration and osmotic support before considering any dose increase.

How does gastric emptying tachyphylaxis change GI symptoms over time on GLP-1 therapy?

As documented by Nauck et al. (Diabetes 2011; PMID: 21430086), vagal gastric emptying delay is most pronounced during initial induction and immediately following dose escalations, then partially attenuates over continuous exposure via vagal receptor tachyphylaxis while central hypothalamic appetite regulation persists.

What is the Protein-First Meal Sequencing protocol to prevent GLP-1 reflux and nausea?

Begin every meal with dense, low-fat protein (poultry, fish, Greek yogurt, egg whites, or clean protein isolate) while stomach capacity is open, follow with cooked vegetables, and place complex carbohydrates and fats last. Stop eating at the first subtle sigh or fullness cue.

When should I hold my GLP-1 dose escalation due to gastrointestinal symptoms?

Hold dose escalation whenever you experience active postprandial nausea, reflux, sulfur eructation, or unaddressed Bristol Type 1-2 constipation at your current dose. Advancing the dose while the vagus nerve is in a Defense state compounds gastric stasis.

What gastrointestinal symptoms on a GLP-1 require calling my prescriber the same day?

Call your prescriber or seek urgent care the same day for persistent vomiting preventing liquid intake for more than 24 hours, severe upper abdominal pain radiating to the back (potential pancreatitis or gallbladder disease), dizziness/dark urine from dehydration, or 5+ days without a bowel movement accompanied by pain.